author-photo

H. Groen

University Medical Center Groningen

24

Papers

499

Citations

Citation Trend

Filter By

Papers (15) Sort By

Journal Conference Others

B11 Accurate Detection of METex14 Mutations in Non-Small Cell Lung Cancer (NSCLC) with Comprehensive Genomic Sequencing: Results from the GEOMETRY Mono-1 Study

2020 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (3)
OA04.02 CheckMate 817: First-Line Nivolumab + Ipilimumab in Patients with ECOG PS 2 and Other Special Populations with Advanced NSCLC

2019 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (27)
P1.01-001 Depth of Target Lesion Response to Brigatinib and Its Association With Outcomes in Patients With ALK+ NSCLC in the ALTA Trial

2017 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (1)
PS04.06 GEOMETRY Mono-1: Phase II, Multicenter Study of MET Inhibitor Capmatinib (INC280) in EGFR wt, MET-dysregulated Advanced NSCLC: Topic: Medical Oncology

2017 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (3)
OA 05.05 Brigatinib in Crizotinib-Refractory ALK+ NSCLC: Updated Efficacy and Safety Results From ALTA, a Randomized Phase 2 Trial

2017 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (14)
MA 17.10 Toxicity Results from the Randomized Phase III NVALT-11 Study of Prophylactic Cranial Irradiation vs. Observation in Stage III NSCLC

2017 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (1)
478TiPA phase II, multicenter, four-cohort study of oral cMET inhibitor capmatinib (INC280) in patients with EGFR wild-type, advanced NSCLC who have received one or two prior lines of systemic therapy for advanced/metastatic disease

2015 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (2)
LBA38_PRDABRAFENIB IN PATIENTS WITH BRAF V600E-MUTANT ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): A MULTICENTER, OPEN-LABEL, PHASE II TRIAL (BRF113928)

2014 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (25)
A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer

2013 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (29)
Long-Term Excess Mortality for Survivors of Non-small Cell Lung Cancer in the Netherlands

2012 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (19)